Medicus Pharma Ltd. (MDCX)

Medicus Pharma Statistics

Total Valuation

Medicus Pharma has a market cap or net worth of $47.49 million. The enterprise value is $45.24 million.

Market Cap	47.49M
Enterprise Value	45.24M

Important Dates

The next estimated earnings date is Saturday, November 22, 2025, before market open.

Earnings Date	Nov 22, 2025
Ex-Dividend Date	n/a

Share Statistics

Medicus Pharma has 20.47 million shares outstanding. The number of shares has increased by 89.21% in one year.

Current Share Class	20.47M
Shares Outstanding	20.47M
Shares Change (YoY)	+89.21%
Shares Change (QoQ)	+16.70%
Owned by Insiders (%)	18.09%
Owned by Institutions (%)	18.63%
Float	13.93M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	11.97
P/TBV Ratio	15.37
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.29, with a Debt / Equity ratio of 1.53.

Current Ratio	1.29
Quick Ratio	1.13
Debt / Equity	1.53
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -352.45% and return on invested capital (ROIC) is -141.79%.

Return on Equity (ROE)	-352.45%
Return on Assets (ROA)	-102.95%
Return on Invested Capital (ROIC)	-141.79%
Return on Capital Employed (ROCE)	-503.24%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	2.35
200-Day Moving Average	3.14
Relative Strength Index (RSI)	47.01
Average Volume (20 Days)	338,790

Short Selling Information

The latest short interest is 253,332, so 1.24% of the outstanding shares have been sold short.

Short Interest	253,332
Short Previous Month	346,039
Short % of Shares Out	1.24%
Short % of Float	1.82%
Short Ratio (days to cover)	0.63

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-17.06M
Pretax Income	-17.09M
Net Income	-17.09M
EBITDA	n/a
EBIT	-17.06M
Earnings Per Share (EPS)	-$1.37

Balance Sheet

The company has $9.67 million in cash and $4.97 million in debt, giving a net cash position of $4.70 million or $0.23 per share.

Cash & Cash Equivalents	9.67M
Total Debt	4.97M
Net Cash	4.70M
Net Cash Per Share	$0.23
Equity (Book Value)	3.25M
Book Value Per Share	0.20
Working Capital	2.45M

Cash Flow

Operating Cash Flow	-15.70M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Medicus Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-89.21%
Shareholder Yield	-89.21%
Earnings Yield	-34.23%
FCF Yield	n/a

Analyst Forecast

The average price target for Medicus Pharma is $23.50, which is 912.93% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$23.50
Price Target Difference	912.93%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on October 25, 2024. It was a reverse split with a ratio of 1:2.

Last Split Date	Oct 25, 2024
Split Type	Reverse
Split Ratio	1:2

Scores

Altman Z-Score	n/a
Piotroski F-Score	1